Screener
Ginkgo Bioworks DNA Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
Based on trailing twelve months.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's free cash flow margin?
- Ginkgo Bioworks (DNA) reported free cash flow margin of -156.3% in Q2 2026.
- How has Ginkgo Bioworks's free cash flow margin changed year-over-year?
- Ginkgo Bioworks's free cash flow margin decreased by 19.8% year-over-year, from -130.4% to -156.3%.
- What is the long-term trend for Ginkgo Bioworks's free cash flow margin?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's free cash flow margin has grown at a 4.8% compound annual growth rate (CAGR), from -98.9% to -119.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Ginkgo Bioworks's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude